23 results
8-K
EX-1.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental
8-K
EX-1.1
14045xvu5u3pqhsp
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
EX-1.1
j279tr56bc tx
16 May 23
Other Events
5:21pm
10-K
409ntst6bg9n4
9 Mar 22
Annual report
7:30am
8-K
EX-10.1
hyqnqymexb4znw9
2 Dec 21
Entry into a Material Definitive Agreement
7:31am
10-Q
1sj00n1 03cc
19 Aug 21
Quarterly report
7:31am
424B4
erwls55
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
EX-1.1
3zq1tmldh 8935ec
30 Apr 21
IPO registration (amended)
5:00pm
S-1/A
ophn671hp2qiu1m
30 Apr 21
IPO registration (amended)
5:00pm